These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17547720)

  • 21. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney and liver disease.
    Shenoy C
    Am J Med; 2008 Jan; 121(1):e11; author reply e13. PubMed ID: 18187056
    [No Abstract]   [Full Text] [Related]  

  • 22. Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity.
    Todd DJ; Kay J
    Curr Rheumatol Rep; 2008 Jul; 10(3):195-204. PubMed ID: 18638427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephrogenic fibrosing dermopathy.
    Firoz BF; Hunzeker CM; Soldano AC; Franks AG
    Dermatol Online J; 2008 May; 14(5):11. PubMed ID: 18627747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal failure and gadolinium: danger.
    Prescrire Int; 2007 Jun; 16(89):114. PubMed ID: 17582934
    [No Abstract]   [Full Text] [Related]  

  • 25. Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review.
    Idée JM; Port M; Medina C; Lancelot E; Fayoux E; Ballet S; Corot C
    Toxicology; 2008 Jun; 248(2-3):77-88. PubMed ID: 18440117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gadolinium chelate-associated nephrogenic systemic fibrosis.
    Kei PL; Chan LP
    Singapore Med J; 2008 Mar; 49(3):181-5. PubMed ID: 18362996
    [No Abstract]   [Full Text] [Related]  

  • 27. [Nephrogenic systemic fibrosis and gadolinium-based contrast media].
    Andréjak M; Thuillier D; Lok C; Gras-Champel V
    Therapie; 2007; 62(2):169-72. PubMed ID: 17582319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of gadolinium in nephrogenic systemic fibrosis: re-examination of a reported cohort with analysis of clinical factors.
    Khurana A; Greene JF; High WA
    J Am Acad Dermatol; 2008 Aug; 59(2):218-24. PubMed ID: 18538448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nephrogenic systemic fibrosis and gadolinium-containing contrast agents: what imaging for chronic kidney failure patients?].
    Ignace S; Juillard L
    Nephrol Ther; 2007 Jul; 3(4):123-5. PubMed ID: 17658437
    [No Abstract]   [Full Text] [Related]  

  • 30. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
    Abraham JL; Thakral C
    Eur J Radiol; 2008 May; 66(2):200-7. PubMed ID: 18374532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients.
    Khurram M; Skov L; Rossen K; Thomsen HS; Marckmann P
    Scand J Urol Nephrol; 2007; 41(6):565-6. PubMed ID: 17934986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nephrogenic systemic fibrosis].
    Artunc F; Schanz S; Metze D; Heyne N
    Dtsch Med Wochenschr; 2008; 133 Suppl():F1. PubMed ID: 18802876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nephrogenic systemic fibrosis].
    Breitschaft A; Stahlmann R
    Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure].
    Michelet PR; Chopard CS; Martin PY; Vallée JP
    Rev Med Suisse; 2008 Mar; 4(147):576-8, 580. PubMed ID: 18402015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure.
    Deo A; Fogel M; Cowper SE
    Clin J Am Soc Nephrol; 2007 Mar; 2(2):264-7. PubMed ID: 17699423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephrogenic systemic fibrosis.
    Nainani N; Panesar M
    Am J Nephrol; 2009; 29(1):1-9. PubMed ID: 18663283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
    Todd DJ; Kagan A; Chibnik LB; Kay J
    Arthritis Rheum; 2007 Oct; 56(10):3433-41. PubMed ID: 17907148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What nephrogenic fibrosing dermopathy might be.
    LeBoit PE
    Arch Dermatol; 2003 Jul; 139(7):928-30. PubMed ID: 12873893
    [No Abstract]   [Full Text] [Related]  

  • 39. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
    Jikki PN
    J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nephrogenic systemic fibrosis].
    Adar T; Rubinger D; Lalazar G; Levi L; Mizrahi M; Bogot RN
    Harefuah; 2008 Oct; 147(10):801-3, 837. PubMed ID: 19039911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.